ScionxBio
ScionxBio is seeking an entry-level scientist to join their international, mission-driven team in engineering next-generation RNA medicines for chronic disease. This development role focuses on accurate experimental work, applying core molecular biology techniques, and building strong habits in data integrity while receiving extensive mentoring. Candidates will grow into independent scientists by contributing to collaborative multidisciplinary research in molecular biology and biochemistry.
Headquarters
Cambridge, England, United Kingdom
Company Size
11-50 employees
Founded
2020
ScionxBio (formerly Eleven Therapeutics) is a biotechnology company that uses synthetic chemistry and AI to engineer xRNA — extended-release RNA medicines designed to turn transient treatments into durable therapies for chronic disease. Its proprietary TERÅ engine combines deep learning and combinatorial chemistry to design and optimize modified RNA molecules with expression lasting weeks to months rather than days. The company's initial therapeutic focus is cardiometabolic disease, with plans to expand its long-acting, multi-pathway platform to other complex chronic conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ScionxBio.
ScionxBio didn’t post a salary, so this is our estimate from similar listings.
23% below the average for this role
Research Associate II, Molecular Biology
MES1007MELA
Research Associate II, Molecular Biology
MES1007MELA
Principal Laboratory Science Professional
University of Colorado
Principal Laboratory Science Professional
University of Colorado
Advisor, Molecular Biology
Eli Lilly and Company
Team Leader - Molecular Biology
USAJOBS